Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium in Bipolar Disorder: Identification of Cellular and Molecular Targets Clinically Relevant
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lithium (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 16 Sep 2013 New trial record
- 09 Aug 2013 Biomarkers information updated